FDA Inspection
Ahmed Kaldun Nossuli M.D., Principal InvestigatorAhmed Kaldun Nossuli M.D., Principal Investigator – FDA Inspection, Aug 14, 2018
Record Details
This FDA Inspection record concerns Ahmed Kaldun Nossuli M.D., Principal Investigator, with an inspection on August 14, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- August 14, 2018
- Product Type
- Drugs
View Company Profile
ID · 2529cb2a-c6b2-41a1-a9c9-553786e90a31
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1062066
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Ahmed Kaldun Nossuli M.D., Principal Investigator
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 18, 2020 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 10, 2013 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Ahmed Kaldun Nossuli M.D., Principal Investigator
- FDA Inspection 1129601 - 2020-09-18
- FDA Inspection 838900 - 2013-06-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.